郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价COVA4231, a potent CD3/CD33 bispecific FynomAb with IgG-like pharmacokinetics for the treatment of acute myeloid leukemia.

期刊：Leukemia发表年份：2019作者：Kristina Klupsch; Vanessa Baeriswyl; Roland Scholz; Joana Dannenberg; Roger Santimaria; David Senn; Elena Kage; Adrian Zumsteg; Isabella Attinger-Toller; Ulrike von der Bey; Susann König-Friedrich; Fanny Dupuy; Wibke Lembke; Clara Albani; Severin Wen
阅读更多 →

药效评价Characterization of the glucosyltransferase activity of Legionella pneumophila effector SetA.

期刊：Naunyn-Schmiedeberg's archives of pharmacology发表年份：2019作者：Nadezhda Levanova; Marcus Steinemann; Kira E Böhmer; Silvia Schneider; Yury Belyi; Andreas Schlosser; Klaus Aktories; Thomas Jank
阅读更多 →

药效评价Validation of an ADCC assay using human primary natural killer cells to evaluate biotherapeutic products bearing an Fc region.

期刊：Journal of immunological methods发表年份：2019作者：Edith González-González; Rosa Camacho-Sandoval; Alexis Jiménez-Uribe; Alejandra Montes-Luna; Ilselena Cortés-Paniagua; Jazmín Sánchez-Morales; Leslie Muñoz-García; Alejandra V Tenorio-Calvo; Carlos A López-Morales; Marco A Velasco-Velázquez; Lenin Pa
阅读更多 →

药效评价DEFINED BIOLOGICAL MODELS OF HIGH-LET RADIATION LESIONS.

期刊：Radiation protection dosimetry发表年份：2019作者：George Iliakis; Veronika Mladenova; Mortoga Sharif; Shipra Chaudhary; Ifigeneia V Mavragani; Aashish Soni; Janapriya Saha; Agnes Schipler; Emil Mladenov
阅读更多 →